Wilmington, DE -- (SBWIRE) -- 09/25/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding MAKO Surgical Corp. (NASDAQ:MAKO) and Oncothyreon Inc (NASDAQ:ONTY).
MAKO Surgical Corp. (NASDAQ:MAKO) a medical device company that markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally is currently up (+82.47%) on 26,745,474 shares traded after MAKO Surgical Corp. Announced Definitive Agreement to Be Acquired by Stryker Corporation for $30 per Share in Cash. MAKO Surgical Corp. (NASDAQ:MAKO) is currently up (+195.9%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about MAKO Surgical Corp. (NASDAQ:MAKO)
Oncothyreon Inc (NASDAQ:ONTY) a clinical-stage biopharmaceutical company that engages in the development of therapeutic products for the treatment of cancer is currently up (+25.00%) on 7,539,307 shares traded after ONCOTHYREON INC. Filed SEC form 8-K, Other Events, Financial Statements and Exhibits. Oncothyreon Inc (NASDAQ:ONTY) is currently up (+56.77%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Oncothyreon Inc (NASDAQ:ONTY)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)